A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow

Administration of NO in experimental stroke reduces stroke lesion volume in permanent and transient models. This may be mediated, in part, by increased cerebral perfusion in permanent models. These data support clinical trials in stroke patients, although the presence of a narrow therapeutic time window may be a limiting factor.